Brain lipidomics: From functional landscape to clinical significance

The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets

Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., Doncheva, N. T., Legeay, M., Fang, T., Bork, P., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1074 · Cited by 8,056 · see citing works

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644 · see citing works

The neuropathological diagnosis of Alzheimer's disease

DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329 · see citing works

Multi-omics approaches to disease

Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953 · see citing works

Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation

Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,188 · see citing works

Polyunsaturated fatty acids and their metabolites in brain function and disease

Bazinet, R. P., & Layé, S. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3820 · Cited by 1,613 · see citing works

Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 1,107 · see citing works

Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools

Sud, M., Fahy, E., Cotter, D., Azam, K., Vadivelu, I., Burant, C., Edison, A. S., Fiehn, O., Higashi, R. M., Nair, K. S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1042 · Cited by 1,008 · see citing works

Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001 · see citing works

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works

Linking lipids to Alzheimer's disease: cholesterol and beyond

Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972 · see citing works

Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium

Bondy, M. L., Scheurer, M. E., Malmer, B., Barnholtz‐Sloan, J. S., Davis, F. G., Il’yasova, D., Kruchko, C. A., McCarthy, B. J., Rajaraman, P., Schwartzbaum, J., et al. (2008) · Cancer · doi:10.1002/cncr.23741 · Cited by 934 · see citing works

Oxidative stress and Parkinson’s disease

Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878 · see citing works

Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics

Čajka, T., & Fiehn, O. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04491 · Cited by 839 · see citing works

Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease

Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 757 · see citing works

Cholesterol metabolism and homeostasis in the brain

Zhang, J., & Liu, Q. (2015) · Protein & Cell · doi:10.1007/s13238-014-0131-3 · Cited by 686 · see citing works

Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions

Dyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., Souza, F. D. C., Dalli, J., Durand, T., Galano, J., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 681 · see citing works

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi

McBride, J. L., Boudreau, R. L., Harper, S. Q., Staber, P. D., Mas, A., Martins, I., Gilmore, B. L., Burstein, H., PELUSO, R. W., Polisky, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801775105 · Cited by 610 · see citing works

Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences

Yang, K., & Han, X. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.08.010 · Cited by 596 · see citing works

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

Han, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 562 · see citing works

Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders

Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00128-6 · Cited by 555 · see citing works

Role of phospholipases in generating lipid second messengers in signal transduction 1

Dennis, E. A., Rhee, S. G., Billah, M. M., & Hannun, Y. A. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.7.1901288 · Cited by 542 · see citing works

Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration

Janssen, C. I. F., & Kiliaan, A. J. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.10.002 · Cited by 515 · see citing works

Membrane phospholipid synthesis and endoplasmic reticulum function

Fagone, P., & Jackowski, S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800049-jlr200 · Cited by 493 · see citing works

Mechanisms of neurodegeneration in Huntington’s disease

Gil‐Mohapel, J., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 480 · see citing works

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study

Varma, V. R., Oommen, A. M., Varma, S., Casanova, R., An, Y., Andrews, R. M., O’Brien, R., Pletniková, O., Troncoso, J. C., Toledo, J. B., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002482 · Cited by 478 · see citing works

Lipid Droplet Binding and Oligomerization Properties of the Parkinson's Disease Protein α-Synuclein

Cole, N. B., Murphy, D. D., Grider, T., Rueter, S. M., Brasaemle, D., & Nussbaum, R. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108414200 · Cited by 466 · see citing works

Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin

Grimm, M. O. W., Grimm, H. S., Pätzold, A. J., Zinser, E. G., Halonen, R., Duering, M., Tschäpe, J., Strooper, B. D., Müller, U., Shen, J., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1313 · Cited by 446 · see citing works

Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease

Tracey, T. J., Steyn, F. J., Wolvetang, E. J., & Ngo, S. T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00010 · Cited by 433 · see citing works

Energy Contribution of Octanoate to Intact Rat Brain Metabolism Measured by ¹³ C Nuclear Magnetic Resonance Spectroscopy

Ebert, D., Haller, R. G., & Walton, M. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05928.2003 · Cited by 427 · see citing works

Altered Lipid Metabolism in Brain Injury and Disorders

Rao, A. M., & Hatcher, J. F. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_9 · Cited by 404 · see citing works

Role of cholesterol and sphingolipids in brain development and neurological diseases

Hussain, G., Wang, J., Rasul, A., Anwar, H., Imran, A., Qasim, M., Zafar, S., Kamran, S., Razzaq, A., Aziz, N., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0965-z · Cited by 383 · see citing works

A neuroscientist's guide to lipidomics

Piomelli, D., Astarita, G., & Rapaka, R. S. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2233 · Cited by 380 · see citing works

Lipidomics from sample preparation to data analysis: a primer

Züllig, T., Trötzmüller, M., & Köfeler, H. C. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02241-y · Cited by 361 · see citing works

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis

Quinville, B. M., Deschenes, N. M., Ryckman, A. E., & Walia, J. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115793 · Cited by 348 · see citing works

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases

Vance, J. E. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010124 · Cited by 342 · see citing works

Mutations associated with familial Parkinson’s disease alter the initiation and amplification steps of α-synuclein aggregation

Flagmeier, P., Meisl, G., Vendruscolo, M., Knowles, T. P. J., Dobson, C. M., Buell, A. K., & Galvagnion, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604645113 · Cited by 323 · see citing works

Identification and quantitation of lipid C=C location isomers: A shotgun lipidomics approach enabled by photochemical reaction

Ma, X., Chong, L., Tian, R., Shi, R., Hu, Y., Ouyang, Z., & Xia, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523356113 · Cited by 321 · see citing works

Sphingolipids: membrane microdomains in brain development, function and neurological diseases

Olsen, A. S. B., & Færgeman, N. J. (2017) · Open Biology · doi:10.1098/rsob.170069 · Cited by 312 · see citing works

The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders

Czubowicz, K., Jęśko, H. M., Wencel, P. L., Lukiw, W. J., & Strosznajder, R. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1448-3 · Cited by 296 · see citing works

Analytical Challenges and Recent Advances in Mass Spectrometry Based Lipidomics

Rustam, Y. H., & Reid, G. E. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04836 · Cited by 284 · see citing works

Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production

Xiong, H., Callaghan, D., Jones, A., Walker, D. G., Lue, L., Beach, T. G., Sue, L. I., Woulfe, J., Xu, H., Stanimirovic, D. B., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.10.005 · Cited by 283 · see citing works

Cell-Type- and Brain-Region-Resolved Mouse Brain Lipidome

Fitzner, D., Bader, J. M., Penkert, H., Bergner, C. G., Su, M., Weil, M., Surma, M. A., Mann, M., Klose, C. D., & Simons, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108132 · Cited by 280 · see citing works

Quinolinic acid is a potent lipid peroxidant in rat brain homogenates

Rı́os, C., & Santamarı́a, A. (1991) · Neurochemical Research · doi:10.1007/bf00966592 · Cited by 272 · see citing works

Role Of Lipids In Brain Injury And Diseases

Rao, A. M., & Hatcher, J. F. (2007) · Future Lipidology · doi:10.2217/17460875.2.4.403 · Cited by 270 · see citing works

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease

Alecu, I., & Bennett, S. A. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00328 · Cited by 260 · see citing works

Assessment of Antioxidant Reserves and Oxidative Stress in Cerebrospinal Fluid after Severe Traumatic Brain Injury in Infants and Children

Bayır, H., Kagan, V. E., Tyurina, Y. Y., Tyurin, V. A., Ruppel, R. A., Adelson, P. D., Graham, S. H., Janesko, K. L., Clark, R. S. B., & Kochanek, P. M. (2002) · Pediatric Research · doi:10.1203/00006450-200205000-00005 · Cited by 258 · see citing works

Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function.

Fantini, J., & Barrantes, F. (2009) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamem.2009.08.016 · Cited by 256 · see citing works

The Role of Lipids in Parkinson’s Disease

Xicoy, H., Wieringa, B., & Martens, G. J. M. (2019) · Cells · doi:10.3390/cells8010027 · Cited by 255 · see citing works

Dysregulation of lipids in Alzheimer’s disease and their role as potential biomarkers

Wong, M. W., Braidy, N., Poljak, A., Pickford, R., Thambisetty, M., & Sachdev, P. S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.008 · Cited by 223 · see citing works

Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes

Hong, S., Ostaszewski, B. L., Yang, T., O’Malley, T. T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., & Selkoe, D. J. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.027 · Cited by 213 · see citing works

Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers

Košiček, M., & Hecimovic, S. K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011310 · Cited by 213 · see citing works

Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s disease

Yao, P. J., Zhu, M., Pyun, E. I., Brooks, A. I., Therianos, S., Meyers, V. E., & Coleman, P. D. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00009-8 · Cited by 205 · see citing works

Alzheimer’s disease: the lipid connection

Hartmann, T., Kuchenbecker, J., & Grimm, M. O. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04715.x · Cited by 199 · see citing works

Lipidomics of Human Brain Aging and Alzheimer's Disease Pathology

Naudí, A., Cabré, R., Jové, M., Ayala, V., Gonzalo‐Benito, H., Portero‐Otín, M., Ferrer, I., & Pamplona, R. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.05.008 · Cited by 199 · see citing works

Large-scale lipid analysis with C=C location and sn-position isomer resolving power

Cao, W., Cheng, S., Yang, J., Feng, J., Zhang, W., Li, Z., Chen, Q., Xia, Y., Ouyang, Z., & Ma, X. (2020) · Nature Communications · doi:10.1038/s41467-019-14180-4 · Cited by 194 · see citing works

Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics

Verheijen, J., & Sleegers, K. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.02.007 · Cited by 189 · see citing works

Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex

Cheng, D., Jenner, A. M., Shui, G., Cheong, W. F., Mitchell, T. W., Nealon, J. R., Kim, W. S., McCann, H., Wenk, M. R., Halliday, G. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017299 · Cited by 189 · see citing works

Local cholesterol increase triggers amyloid precursor protein‐Bacel clustering in lipid rafts and rapid endocytosis

Marquer, C., Devauges, V., Cossec, J., Liot, G., Lécart, S., Saudou, F., Duyckaerts, C. J., Lévêque‐Fort, S., & Potier, M. (2011) · The FASEB Journal · doi:10.1096/fj.10-168633 · Cited by 188 · see citing works

Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease

Lane, R. M., & Farlow, M. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400486-jlr200 · Cited by 182 · see citing works

Ion mobility conformational lipid atlas for high confidence lipidomics

Leaptrot, K. L., May, J. C., Dodds, J. N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08897-5 · Cited by 182 · see citing works

Organization and Evolution of Brain Lipidome Revealed by Large-Scale Analysis of Human, Chimpanzee, Macaque, and Mouse Tissues

Bożek, K., Wei, Y., Zheng, Y., Liu, X., Xiong, J., Sugimoto, M., Tomita, M., Pääbo, S., Sherwood, C. C., Hof, P. R., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.003 · Cited by 175 · see citing works

Lipids in Psychiatric Disorders and Preventive Medicine

Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175 · see citing works

Polyunsaturated Fatty Acid Synthesis and Release

Moore, S. A. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:2-3:195 · Cited by 174 · see citing works

Effects of Dietary Sphingomyelin on Central Nervous System Myelination in Developing Rats

Oshida, K., Shimizu, T., Takase, M., Tamura, Y., Shimizu, T., & Yamashiro, Y. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000054654.73826.ac · Cited by 171 · see citing works

Cholesterol metabolism in the brain and its association with Parkinson’s disease.

Jin, U., Park, S. J., & Park, S. M. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.5.554 · Cited by 169 · see citing works

Molecular diagnostics of neurodegenerative disorders

Agrawal, M., & Biswas, A. (2015) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2015.00054 · Cited by 164 · see citing works

Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions

Fabelo, N., Martín, M. V., Marín, R., Moreno, D., Ferrer, I., & Díaz, M. L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.005 · Cited by 164 · see citing works

Lipids and Their Trafficking: An Integral Part of Cellular Organization

Jackson, C. L., Walch, L., & Verbavatz, J. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.09.030 · Cited by 162 · see citing works

Intracellular Cholesterol Trafficking and Impact in Neurodegeneration

Arenas, F., García‐Ruiz, C., & Fernández-Checa, J. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00382 · Cited by 161 · see citing works

Abnormal brain cholesterol homeostasis in Alzheimer’s disease-a targeted metabolomic and transcriptomic study

Varma, V. R., Büşra Lüleci, H., Oommen, A. M., Varma, S., Blackshear, C. T., Griswold, M. E., An, Y., Roberts, J. A., O’Brien, R., Pletnikova, O., et al. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00064-9 · Cited by 153 · see citing works

Presenilin mutations linked to familial Alzheimer's disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism

Landman, N., Jeong, S. Y., Shin, S. Y., Voronov, S. V., Serban, G., Kang, M. S., Park, M. K., Di Paolo, G., Chung, S., & Kim, T.-W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604954103 · Cited by 149 · see citing works

Lipid Transport and Metabolism at the Blood-Brain Interface: Implications in Health and Disease

Pifferi, F., Laurent, B., & Plourde, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.645646 · Cited by 149 · see citing works

Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence

Hampel, H. J., Nisticò, R., Seyfried, N. T., Levey, A. I., Modeste, E. S., Lemercier, P., Baldacci, F., Toschi, N., Garaci, F., Perry, G. L., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101346 · Cited by 142 · see citing works

Glycolipid and ganglioside metabolism imbalances in Huntington's disease

Desplats, P., Denny, C. A., Kass, K. E., Gilmartin, T., Head, S. R., Sutcliffe, J. G., Seyfried, T. N., & Thomas, E. A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.05.003 · Cited by 139 · see citing works

Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods

van Kruining, D., Luo, Q., van Echten‐Deckert, G., Mielke, M. M., Bowman, A. P., Ellis, S. R., Oliveira, T. G., & Martínez‐Martínez, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.009 · Cited by 135 · see citing works

Troxerutin protects against high cholesterol-induced cognitive deficits in mice

Lu, J. L., Wu, D.-M., Zheng, Z.-H., Zheng, Y., Hu, B., & Zhang, Z.-F. (2011) · Brain · doi:10.1093/brain/awq376 · Cited by 135 · see citing works

Genes and environments, development and time

Boyce, W. T., Sokolowski, M. B., & Robinson, G. E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016710117 · Cited by 135 · see citing works

LIPID MAPS: Serving the next generation of lipid researchers with tools, resources, data, and training

O’Donnell, V. B., Dennis, E. A., Wakelam, M. J. O., & Subramaniam, S. (2019) · Science Signaling · doi:10.1126/scisignal.aaw2964 · Cited by 132 · see citing works

Structural insights into α-synuclein monomer–fibril interactions

Kumari, P., Ghosh, D., Vanas, A., Fleischmann, Y., Wiegand, T., Jeschke, G., Riek, R., & Eichmann, C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012171118 · Cited by 132 · see citing works

lipidr: A Software Tool for Data Mining and Analysis of Lipidomics Datasets

Mohamed, A., Molendijk, J., & Hill, M. M. C. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00082 · Cited by 125 · see citing works

Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics

Armitage, E. G., & Southam, A. D. (2016) · Metabolomics · doi:10.1007/s11306-016-1093-7 · Cited by 121 · see citing works

Endoplasmic Reticulum Stress and Parkinson’s Disease: The Role of HRD1 in Averting Apoptosis in Neurodegenerative Disease

Omura, T., Kaneko, M., Okuma, Y., Matsubara, K., & Nomura, Y. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/239854 · Cited by 113 · see citing works

Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro

Wang, J., & Yu, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307224110 · Cited by 111 · see citing works

Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention

Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110 · see citing works

An age-old story of dementia

Drew, L. (2018) · Nature · doi:10.1038/d41586-018-05718-5 · Cited by 102 · see citing works

GM1 ganglioside regulates the proteolysis of amyloid precursor protein

Zha, Q., Ruan, Y., Hartmann, T., Beyreuther, K. T., & Zhang, D. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001509 · Cited by 100 · see citing works

A Perspective: Active Role of Lipids in Neurotransmitter Dynamics

Postila, P. A., & Róg, T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01775-7 · Cited by 93 · see citing works

Quantitative structural multiclass lipidomics using differential mobility: electron impact excitation of ions from organics (EIEIO) mass spectrometry

Baba, T., Campbell, J. L., Blanc, J. C. Y. L., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.d083261 · Cited by 89 · see citing works

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease

Pardo, A. D., Amico, E., Basit, A., Armirotti, A., Joshi, P. K., Neely, M. D., Vuono, R., Castaldo, S., Digilio, A. F., Scalabrì, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05709-y · Cited by 81 · see citing works

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Lu, B., Bridges, D., Yang, Y., Fisher, K., Cheng, A., Chang, L. C., Meng, Z., Lin, J. D., Downes, M., Yu, R. T., et al. (2014) · Diabetes · doi:10.2337/db13-1531 · Cited by 80 · see citing works

APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain

Lefterov, I., Wolfe, C. M., Fitz, N. F., Nam, K. N., Letronne, F., Biedrzycki, R. J., Kofler, J., Han, X., Wang, J., Schug, J., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0558-0 · Cited by 74 · see citing works

The Mutation Matters: CSF Profiles of GCase , Sphingolipids, α‐Synuclein in PD GBA

Lerche, S., Schulte, C., Wurster, I., et al. (2021) · Movement Disorders · doi:10.1002/mds.28472 · Cited by 74 · see citing works

Proteomics of neurodegenerative diseases: analysis of human post‐mortem brain

Li, K. W., Ganz, A. B., & Smit, A. B. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14603 · Cited by 73 · see citing works

Metabolic Profiling Identifies Phospholipids as Potential Serum Biomarkers for Schizophrenia

Wang, D., Cheng, S. L., Fei, Q., Gu, H., Raftery, D., Cao, B., Sun, X., Yan, J., Zhang, C., & Wang, J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.008 · Cited by 73 · see citing works

LipidSig: a web-based tool for lipidomic data analysis

Lin, W.-J., Shen, P.-C., Liu, H.-C., Cho, Y.-C., Hsu, M.-K., Lin, I.-C., Chen, G. T. Y., Yang, J., Ma, W., & Cheng, W. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab419 · Cited by 70 · see citing works

Lipid peroxidation in patients with schizophrenia

Dietrich‐Muszalska, A., & Kontek, B. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02132.x · Cited by 69 · see citing works

Phospholipase D1 regulates autophagic flux and clearance of α-synuclein aggregates

Bae, E.-J., Lee, H.-J., Jang, Y.-H., Michael, S., Masliah, E., Min, D. S., & Lee, S. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.30 · Cited by 69 · see citing works

Coping with psychotic symptoms in the early phases of schizophrenia.

Boschi, S., Adams, R. E., Bromet, E. J., Lavelle, J., Everett, E., & Galambos, N. (2000) · American Journal of Orthopsychiatry · doi:10.1037/h0087710 · Cited by 67 · see citing works

Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease

Xu, J., Bankov, G., Kim, M. G., Wretlind, A., Lord, J., Green, R., Hodges, A., Hye, A., Aarsland, D., Velayudhan, L., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00215-0 · Cited by 66 · see citing works

Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study

Fernández‐Irigoyen, J., Cartas‐Cejudo, P., Iruarrizaga‐Lejarreta, M., & Santamaría, E. (2021) · Biomedicines · doi:10.3390/biomedicines9050491 · Cited by 66 · see citing works

Nano-HPLC–MS analysis of phospholipids in cerebrospinal fluid of Alzheimer’s disease patients—a pilot study

Košiček, M., Kirsch, S., Béné, R., Trkanjec, Z., Titlić, M., Bîndilă, L., Peter‐Katalinić, J., & Hecimovic, S. K. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4273-8 · Cited by 63 · see citing works

Identification of Abundant Alkyl Ether Glycerophospholipids in the Human Lens by Tandem Mass Spectrometry Techniques

Deeley, J. M., Thomas, M. C., Truscott, R. J. W., et al. (2009) · Analytical Chemistry · doi:10.1021/ac802395d · Cited by 62 · see citing works

An Ambient Assisted Living Approach in Designing Domiciliary Services Combined With Innovative Technologies for Patients With Alzheimer’s Disease: A Case Study

Cavallo, F., Aquilano, M., & Arvati, M. (2015) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317514539724 · Cited by 60 · see citing works

PC and PE synthesis: Mixed micellar analysis of the cholinephosphotransferase and ethanolaminephosphotransferase activities of human choline/ethanolamine phosphotransferase 1 (CEPT1)

Wright, M. M., & McMaster, C. R. (2002) · Lipids · doi:10.1007/s11745-002-0947-6 · Cited by 60 · see citing works

Saturated free fatty acids and association with memory formation

Wallis, T. P., Venkatesh, B. G., Narayana, V. K., Kvaskoff, D., Ho, A., Sullivan, R., Windels, F., Sah, P., & Meunier, F. A. (2021) · Nature Communications · doi:10.1038/s41467-021-23840-3 · Cited by 59 · see citing works

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease

Mori, A., Imai, Y., & Hattori, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093301 · Cited by 58 · see citing works

Brain lipidomics as a rising field in neurodegenerative contexts: Perspectives with Machine Learning approaches.

Castellanos, D. B., Martín-Jiménez, C., Rojas-Rodríguez, F., Barreto, G., & Santos, J. G. (2021) · Frontiers in neuroendocrinology (Print) · doi:10.1016/j.yfrne.2021.100899 · Cited by 58 · see citing works

Evidence for altered cell membrane lipid composition in postmortem prefrontal white matter in bipolar disorder and schizophrenia

Ghosh, S., Dyer, R., & Beasley, C. L. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.08.009 · Cited by 56 · see citing works

Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases

Cognata, V. L., Morello, G., & Cavallaro, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094820 · Cited by 56 · see citing works

Mini review: Lipids in Peripheral Nerve Disorders

Hornemann, T. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135455 · Cited by 55 · see citing works

Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases

Marín, R., Fabelo, N., Martín, M. V., Garcia‐Esparcia, P., Ferrer, I., Quinto‐Alemany, D., & Díaz, M. L. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.027 · Cited by 54 · see citing works

Lipid Metabolism at Membrane Contacts: Dynamics and Functions Beyond Lipid Homeostasis

Xu, J., & Huang, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.615856 · Cited by 54 · see citing works

Reliable detection of macromolecules in single‐volume 1H NMR spectra of the human brain

Seeger, U., Mader, I., Nägele, T., et al. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1127 · Cited by 53 · see citing works

Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix‐assisted laser desorption/ionization‐imaging mass spectrometry

Mendis, L. H. S., Grey, A. C., Faull, R. L. M., & Curtis, M. A. (2016) · Brain and Behavior · doi:10.1002/brb3.517 · Cited by 52 · see citing works

Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study

Xicota, L., Ichou, F., Lejeune, F.-X., Colsch, B., Tenenhaus, A., Leroy, I., Fontaine, G., Lhomme, M., Bertin, H., Habert, M.-O., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.051 · Cited by 51 · see citing works

Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease

Kline, A. D. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt135 · Cited by 49 · see citing works

Cholesteryl ester levels are elevated in the caudate and putamen of Huntington’s disease patients

Phillips, G. R., Hancock, S. E., Brown, S. H. J., Jenner, A. M., Kreilaus, F., Newell, K. A., & Mitchell, T. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-76973-8 · Cited by 49 · see citing works

Alteration of Lipids and Amino Acids in Plasma Distinguish Schizophrenia Patients from Controls: A Targeted Metabolomics Study

Liu, Y., Song, X., Liu, X., Pu, J., Gui, S., Xu, S., Tian, L., Zhong, X., Zhao, L., Wang, H., et al. (2021) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13194 · Cited by 48 · see citing works

Application of next-generation sequencing technologies in Neurology.

Jiang, T., Tan, M., Tan, L., & Yu, J. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2014.11.11 · Cited by 48 · see citing works

From Common to Rare Variants: The Genetic Component of Alzheimer Disease

Nicolas, G., Charbonnier, C., & Campion, D. (2016) · Human Heredity · doi:10.1159/000452256 · Cited by 47 · see citing works

UPLC-QqQ/MS-Based Lipidomics Approach To Characterize Lipid Alterations in Inflammatory Macrophages

Lee, J. W., Mok, H. J., Lee, D., Park, S. C., Kim, G., Lee, S.-E., Lee, Y., Kim, K. P., & Kim, H. D. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00848 · Cited by 47 · see citing works

Evaluation of ultraviolet photodissociation tandem mass spectrometry for the structural assignment of unsaturated fatty acid double bond positional isomers

Fang, M., Rustam, Y. H., Palmieri, M., Sieber, O. M., & Reid, G. E. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02446-6 · Cited by 47 · see citing works

Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure

McClay, J. L., Adkins, D. E., Vunck, S. A., Batman, A. M., Vann, R. E., Clark, S. L., Beardsley, P. M., & van den Oord, E. J. C. G. (2012) · Metabolomics · doi:10.1007/s11306-012-0456-y · Cited by 45 · see citing works

Lipid mediators of inflammation as novel plasma biomarkers to identify patients with bacteremia

To, K. K., Lee, K.-C., Wong, S. S. Y., Lo, K.-C., Lui, Y.-M., Jahan, A. S., Wu, A. L., Ke, Y., Law, C. Y., Sze, K. H., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.02.011 · Cited by 43 · see citing works

Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges

Kett, L. R., & Dauer, W. T. (2016) · Movement Disorders · doi:10.1002/mds.26797 · Cited by 42 · see citing works

ESI–MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts

Wildburger, N. C., Wood, P. L., Gumin, J., Lichti, C. F., Emmett, M. R., Lang, F. F., & Nilsson, C. L. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00076 · Cited by 42 · see citing works

Ovariectomy and 17β-estradiol alter transcription of lipid metabolism genes and proportions of neo-formed n-3 and n-6 long-chain polyunsaturated fatty acids differently in brain and liver

Alessandri, J., Extier, A., Al-Gubory, K. H., Goustard, B., Baudry, C., LePoupon, C., Lavialle, M., & Guesnet, P. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.005 · Cited by 37 · see citing works

Parallel metabolomics and lipidomics enables the comprehensive study of mouse brain regional metabolite and lipid patterns

Yu, H., Villanueva, N., Bittar, T. P., Arsenault, E., Labonté, B., & Huan, T. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.09.051 · Cited by 35 · see citing works

Assessment of ganglioside age-related and topographic specificity in human brain by Orbitrap mass spectrometry

Sârbu, M., Dehelean, L., Munteanu, C. V. A., et al. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.01.010 · Cited by 31 · see citing works

Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia

Liu, Y., Chan, D. K. Y., Thalamuthu, A., Wen, W. X., Jiang, J., Paradise, M., Lee, T., Crawford, J. D., Wong, M. W. K., Xu, Y. H., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.001 · Cited by 31 · see citing works

Discovering novel brain lipids by liquid chromatography/tandem mass spectrometry

Guan, Z. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.03.002 · Cited by 29 · see citing works

Proteomic and lipidomic profiling of demyelinating lesions identifies fatty acids as modulators in lesion recovery

Penkert, H., Bertrand, A., Tiwari, V., Breimann, S., Müller, S. A., Jordan, P. M., Gerl, M. J., Klose, C. D., Cantuti‐Castelvetri, L., Bosch-Queralt, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109898 · Cited by 28 · see citing works

How does the brain remove its waste metabolites from within?

Cheng, Y., & Haorah, J. (2019) · PubMed Central · Cited by 28 · see citing works

Phospholipid transfer protein (PLTP) deficiency accelerates memory dysfunction through altering amyloid precursor protein (APP) processing in a mouse model of Alzheimer's disease

Tong, Y., Sun, Y., Tian, X., Zhou, T., Wang, H., Zhang, T., Zhan, R., Zhao, L., Kuerban, B., Li, Z., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv262 · Cited by 26 · see citing works

Pathway‐based integration of multi‐omics data reveals lipidomics alterations validated in an Alzheimer's disease mouse model and risk loci carriers

Garcia‐Segura, M. E., Durainayagam, B. R., Liggi, S., Graça, G., Jiménez, B., Dehghan, A., Tzoulaki, I., Karaman, İ., Elliott, P., & Griffin, J. L. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15719 · Cited by 25 · see citing works

Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia

Correia, B. S. B., Nani, J. V. S., Ricardo, R. W., Stanišić, D., Costa, T. B. B. C., Hayashi, M. A. F., & Tasić, L. (2021) · Biomedicines · doi:10.3390/biomedicines9030235 · Cited by 25 · see citing works

Matrix-Assisted Laser Desorption/Ionization (MALDI) Imaging Mass Spectrometry (IMS): A Challenge for Reliable Quantitative Analyses

Kubo, A., Kajimura, M., & Suematsu, M. (2012) · Mass Spectrometry · doi:10.5702/massspectrometry.a0004 · Cited by 24 · see citing works

Mapping the distribution of double bond location isomers in lipids across mouse tissues

Ren, H., Triebl, A., Muralidharan, S., et al. (2021) · The Analyst · doi:10.1039/d1an00449b · Cited by 24 · see citing works

Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington’s Disease Mouse Striatum

Iuliano, M., Seeley, C., Sapp, E., Jones, E. L., Martin, C., Li, X., DiFiglia, M., & Kegel-Gleason, K. B. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.618391 · Cited by 23 · see citing works

Comprehensive Profiling of Surface Gangliosides Extracted from Various Cell Lines by LC-MS/MS

Lee, J., Hwang, H., Kim, S., et al. (2019) · Cells · doi:10.3390/cells8111323 · Cited by 22 · see citing works

New players in old amyloid precursor protein‐processing pathways

Roßner, S. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.004 · Cited by 20 · see citing works

Unbiased Lipidomics and Metabolomics of Human Brain Samples

Astarita, G., Stocchero, M., & Paglia, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_17 · Cited by 19 · see citing works

Disentangling Lipid Isomers by High-Resolution Differential Ion Mobility Spectrometry/Ozone-Induced Dissociation of Metalated Species

Berthias, F., Poad, B. L. J., Thurman, H. A., et al. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.1c00251 · Cited by 17 · see citing works

Regional Lipid Expression Abnormalities Identified Using MALDI IMS Correspond to MRI-Defined White Matter Hyperintensities within Post-mortem Human Brain Tissues

Pinsky, W., Harris, A. J., Roseborough, A. D., Wang, W., KHAN, A. R., Jurčić, K., Yeung, K. K. ‐., Pasternak, S., & Whitehead, S. N. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c05017 · Cited by 14 · see citing works

Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions

Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97 · see citing works

Extracellular vesicles: New horizons in neurodegeneration

Chen, J., Tian, C., Xiong, X., Yang, Y., & Zhang, J. (2025) · eBioMedicine · doi:10.1016/j.ebiom.2025.105605 · Cited by 53 · see citing works

Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers

Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36 · see citing works

Spatial-temporal lipidomics reveals dysregulated lipid metabolism in mouse brain during Alzheimer’s disease progression

Li, H., Zhao, Z., Zhu, L., Tan, Y., Zhang, Z., Zhang, Z., Kang, J., Lu, H., Peng, W., & Wu, Q. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.044 · Cited by 3 · see citing works

Dyslipidemia-Induced Mitochondrial Dysfunctions in the Brains Does Not Reach Pathological Levels in the ApoE-Knockout Mice

Hsu, C.-H., Chu, P.-W., Chen, Y.-Y., Ho, M.-H., Liao, E.-C., & Chen, S.-K. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04842-3